NZ238356A - Increasing the bioavailability of buspirone (an azaspirondecanedione) relative to its major metabolite by oral administration of a buspirone controlled/extended release formulation - Google Patents

Increasing the bioavailability of buspirone (an azaspirondecanedione) relative to its major metabolite by oral administration of a buspirone controlled/extended release formulation

Info

Publication number
NZ238356A
NZ238356A NZ238356A NZ23835688A NZ238356A NZ 238356 A NZ238356 A NZ 238356A NZ 238356 A NZ238356 A NZ 238356A NZ 23835688 A NZ23835688 A NZ 23835688A NZ 238356 A NZ238356 A NZ 238356A
Authority
NZ
New Zealand
Prior art keywords
buspirone
azaspirondecanedione
bioavailability
increasing
controlled
Prior art date
Application number
NZ238356A
Inventor
Alf Gunner Martin Nicklasson
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8704097A external-priority patent/SE8704097D0/en
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NZ238356A publication Critical patent/NZ238356A/en

Links

NZ238356A 1987-10-22 1988-10-18 Increasing the bioavailability of buspirone (an azaspirondecanedione) relative to its major metabolite by oral administration of a buspirone controlled/extended release formulation NZ238356A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8704097A SE8704097D0 (en) 1987-10-22 1987-10-22 ORAL FORMULATION OF BUSPIRONE AND SALTS THEREOF
NZ226604A NZ226604A (en) 1987-10-22 1988-10-18 Sustained release oral formulation containing buspirone as the active ingredient; process for preparation

Publications (1)

Publication Number Publication Date
NZ238356A true NZ238356A (en) 1993-06-25

Family

ID=26650823

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ238356A NZ238356A (en) 1987-10-22 1988-10-18 Increasing the bioavailability of buspirone (an azaspirondecanedione) relative to its major metabolite by oral administration of a buspirone controlled/extended release formulation

Country Status (1)

Country Link
NZ (1) NZ238356A (en)

Similar Documents

Publication Publication Date Title
HUT47843A (en) Process for producing pharmaceutical with regulated active ingredient release
IT8667635A0 (en) CONTROLLED RELEASE DEVICE FOR THE ADMINISTRATION OF A BENEFICIAL AGENT TO A RECEPTOR
IT1164548B (en) GALENIC FORMS OF ADMINISTRATION OF MEDICATIONS ORALLY, WITH SCHEDULED LIBERATION, AND THEIR PREPARATION PROCEDURES
HK12395A (en) Formulation for preparing sustained release drugs for oral administration
IL88736A0 (en) Prolonged release pharmaceutical formula
AU7960287A (en) Prodrug derivatives of carboxylic acid drugs
EP0288138A3 (en) Spheroids for the controlled release of a drug
RO75336A (en) PROCEDURE FOR PREPARATION OF A PHARMACEUTICAL FORM INTENDED FOR THE TRANSMERCIAL ADMINISTRATION OF CLONIDINE
NZ237936A (en) 2-deoxy-neuraminic acid derivatives & analogs; antiviral medicaments
NO170889C (en) PROCEDURE FOR PREPARING A STABLE CRYSTALLINE DIET OR TRIHYDRATE OF 7BETA - ((Z) -2- (2-AMINOTIAZOL-4-YL) -4-CARBOXYBUT-2-ENOYLAMINO) -3-CEFEM-4-CARBOXYL
GR880100491A (en) Method for the preparation of aketaminophane formulations orally slowly released
NO882103D0 (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION
AU6893287A (en) Sustained release pharmaceutical preparation
IT7830961A0 (en) PROCEDURE FOR THE PREPARATION OF DL-2-AMINO-4-(HYDROXY)(METHYL)PHOSPHINEYLBUTYRIC ACID
IL83349A (en) Stable pharmaceutical composition comprising cimetidine polymorph b suitable for oral administration
GB2226804B (en) Process for preparing microcapsules providing the rapid release of a drug as active ingredient
DK645788A (en) USE OF ERGOLIN DERIVATIVES FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION
AU2228888A (en) Aqueous pharmaceutical preparation for oral administration
AU6529190A (en) Use of lecithin analogs as antiviral drugs as well as new compounds
NO179396C (en) Process for the preparation of a drug administration form for ruminants
GB2151921B (en) Controlled release form of ketoprofen for oral administration
DK23490A (en) IMPLANTED ANTIBIOTIC PREPARATION WITH REGULATED RELEASE
IL88020A0 (en) Oral formulation of buspirone and salts thereof
NZ238356A (en) Increasing the bioavailability of buspirone (an azaspirondecanedione) relative to its major metabolite by oral administration of a buspirone controlled/extended release formulation
GB2190287B (en) Controlled release ketoprofen pharmaceutical formulation

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)